Edwards Sidesteps Crowded Coronary Stent Field, Targets Peripheral Stents
This article was originally published in The Gray Sheet
Executive Summary
Edwards Lifesciences' vascular division will focus on peripheral stent technology development for the next few years, foregoing the significantly larger coronary stent market